Gastroenterology

Latest News

canada biosimilars | Image credit: Rawf8 - stock.adobe.com
British Columbia’s Biosimilar Switching Program Saves $732 Million in 5 Years

June 18th 2024

British Columbia's 2019 Biosimilars Initiative, which transitioned over 40,000 patients from costly branded biologics to biosimilars, saved around $732 million in 5 years, maintained comparable health outcomes, and reinvested the savings to improve the province's public payer program.

child with inflammatory bowel disease | Image credit: zinkevych - stock.adobe.com
Real-World Study: Nonmedical Switch to Infliximab Biosimilar Is Safe, Effective in Pediatric Patients With IBD

June 12th 2024

doctor and patient | Image credit: sebra - stock.adobe.com
Switching Patients With IBD to Infliximab, Adalimumab Biosimilars Did Not Impact Efficacy

June 8th 2024

digestive tract | Image credit: sdecoret - stock.adobe.com
Posters Capture Clinical Impacts of Infliximab in Super-Responders, Pregnant Patients With IBD

June 1st 2024

Gastro roundup banner
Biosimilars Gastroenterology Roundup: May 2024

May 30th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.